ARCHIVES

Durant Suggests Six Efforts Needed For Survival Of Clinical Research

This article is from The Cancer Letter archive.

Vol. 12 No. 22 | May 30, 1986

Download PDF Visit The Full Archive

Related Articles

NCI, Komen Foundation Fund Summit meeting On Breast Cancer

October 8, 1993

NIH Lifts Patient Limit On Gene Modified TIL Study; 6 Treated So Far

April 13, 1990

Gritz is president-elect of Society for Research on Nicotine and Tobacco.

September 23, 2005

FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says.

January 14, 2005

ASCO to form commission to study tobacco problem.

January 23, 2004

Clinical Societies, Patient Groups Need New Alliance, Glick Proposes to ASCO

May 24, 1996